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Helicobacter pyloi has been shown, along with other Helicobacter
species to produce effector molecules that induce substantial physio-
logical changes on acid and pepsin secretion. The effects are clinically
evident, and long-term achlorhydria may be arisk factor for gastric can-
cer. Further identification and characterization of the factors may lead
to additional understanding of gastric physiology.
INTRODUCTION
Helicobacter pylori is regarded as a slow bacterium [1] that parasitizes the gastric
mucosa for long periods. It has evolved the unique capacity to colonize a niche under the
gastric mucus layer in close association with the gastric epithelium. The close proximity
of a single bacterial species to physiologically active epithelial cells provides an opportu-
nity to observe the consequences ofthis interaction. It has become clear since the seminal
paper of Marshall and Warren [2] that the concept of Koch's postulates as applied to H.
pylori infection are tenable only to a limited degree. Koch postulated that 1) the organism
must be present in every case; 2) the organism must be isolated and grown in pure culture;
3) the organism must cause the specific disease when inoculated into a susceptible animal;
and 4) the organism must the be recovered from the animal and identified. These postu-
lates apply to H. pylori-induced gastritis, but they do not yet apply to peptic ulcer and gas-
tric cancer. Hill [3] proposed less specific postulates that are more appropriate toH. pylori,
which has been associated with a variety of different disorders. These postulates involve
issues of temporality, strength, dose-response, reversibility, consistency and biological
plausibility.
The majority of those infected with H. pylori never develop more than a mild histo-
logical change in the gastric mucosa. The clear clinical associations are epidemic [4] and
sporadic hypochlorhydria [5], peptic ulcer disease [6], gastric carcinoma [7, 8], primary
gastric lymphoma [9] and mucosa associated lymphoid tissue (MALT)b lymphoma [10].
The conditions that predispose to each of the above disorders are likely to vary and rep-
resent the end result ofdifferent interactions between host and bacterium. An example of
the interaction of the parietal cell and H. pylori is that peptic ulcers require the presence
of acid secretion, not an achlorhydric stomach as occurs in epidemic hypochlorhydria.
Similarly, there is an old clinical observation that duodenal ulcer patients are protected
from the later development of gastric cancer. This anecdotal observation has been given
further credence by Parsonnet et al. [9] who noted a negative correlation between duode-
nal ulcer and gastric cancer.
It is becoming clear that there are variations in the properties ofthe individual isolates
ofH. pylori and that these can change as a function ofthe duration ofinfection orthe local
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environment. The clearest data on this phenomenon is the alteration in the genotype ofH.
pylori by the insertion of a 20 to 30 kilobase piece ofDNA [11], termed a "pathogenicity
island" by Stanley Falkow. This DNA insert carries homologues of as many as 20 viru-
lence genes from differentsources, whichinclude an exportermolecule forBordetellaper-
tussis, a malarial protein and an invasion factor for Salmonella among others. The pres-
ence ofthis insert creates the genotype, referred to as cag 1 orType 1, and it is present in
about 70 percent of strains isolated. Furthermore, if it is present there is a greater likeli-
hood of the development ofpeptic ulcer disease or gastric cancer. It should, however, be
emphasized that the majority of those infected with H. pylori never develop clinically
apparent disease.
The effect that H. pylori has on the chiefcell has received little interest. The patterns
ofchange ofthe serum pepsinogens as a genetic marker for those susceptible to ulcer dis-
ease and gastric cancerhave become a historical footnote [12], since the abnormal patterns
resolve after the eradication of H. pylori [13]. Pepsin, however, is thought to play a role
in peptic ulceration, and the possible role that H. pylori has in increasing pepsin secretion
is discussed below.
CLINICAL OBSERVATIONS ON THE EARLY PHASE
OF H. PYLORI INFECTION AND PARIETAL CELL FUNCTION
The earliest description of what was likely to be H. pylon infection was by Sir
William Osler, who eloquently described the acute signs and symptoms ofinfection [14].
He did not describe the incidence of his observations, but his description closely resem-
bles that of subsequent volunteer studies [15, 16] and those with closely observed inad-
vertent infection [5]. The consensus of description of the early clinical changes are that
within seven days of infection there may be headache, nausea and vomiting, epigastric
pain and halitosis. Changes in bowel habit are variable: sometimes mild diarrhea develops
and others have constipation. Symptoms subside within three days. Signs include a mild
fever, particularly in children, a coated tongue, epigastric tenderness and achlorhydria,
starting about day eight after infection.
Two investigators took the extreme measure ofdeliberately infecting themselves with
H. pylori. Marshall reported epigastric distress, vomiting and halitosis after ingesting an
isolate of H. pylori (1 x 109 cfu) obtained from a patient with non-ulcer dyspepsia [17].
Morris ingested a different isolate andreported similarchanges. In addition, he was found
to have developed achlorhydriaeightdays after infection. He had a gastric pH of7.6 [15].
This achlorhydria persisted until he took doxycycline on day 26 after the initiation of
infection. Acid secretion became normal within three days. His gastric pH went from 7 to
1.6, but H. pylori persisted as did the acute superficial gastritis. At no time was there any
evidence for the loss ofparietal cells. A similar case was reported by Graham et al. [5] in
a volunteer who had been infected by the passage of an endoscope during a study on the
effects ofaspirin on the gastric mucosa. In this volunteer, there was a transient increase in
acid and pepsin release, followed in the second week by the disappearance of basal acid
secretion. Eight weeks after infection, acid secretion became detectable and had sponta-
neously returned to normal by six months. These studies provide strong evidence for the
role of H. pylori in,the etiology of achlorhydria. Earlier studies [18, 19] of similar phe-
nomena, although less clearly linked to H. pylori infection, appear comparable and pro-
vide additional insights into the capacity ofH. pylon to alter acid secretion.
In a study ofgastric acid secretion in 34 volunteers, 17 became achlorhydric for 53
to 235 days [4]. Ofthese, eight were entirely asymptomatic; the remaining nine had epi-
gastric pain; nausea developed in four and vomiting in two. Those ofthe 37 who became
hypochlorhydric were significantly younger (25 ± 1.0 years vs. 41 + 3.0 years). All the
patients with achlorhydria had gastritis with intactparietal cells anddemonstrated araised
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serum gastrin to about twice the normal range. Interestingly, the elevated serum gastrin is
numerically comparable to the elevations seen in H. pylori infection when acid secretion
is within the normal range. Among the 37 volunteers were three who did not recover their
acid secretion as long as they were studied. In addition, one patient with pre-existent
Zollinger Ellison syndrome of four years duration became achlorhydric in Nov. 1976. In
March 1977 and in March 1978, he still had a severe gastritis but no acid secretion. During
follow-up, the serum gastrin remained very high, implying that the gastrinoma was still
functional. Studies of mucosal permeability were performed on some of the achlorhydric
patients to determine whether the loss of acid secretion was due to back diffusion. No evi-
dence for this was found. There have been other reports of epidemics and sporadic cases
of apparent parietal cell failure, including one with Zollinger-Ellison syndrome [20]. All
of the cases with achlorhydria had histological gastritis and normal but presumably non-
functional parietal cells.
In a study designed to determine the prevalence of H. pylori infection in healthy
asymptomatic healthy young adult volunteers [21], 25 percent of those with H. pylori
infection had diminished acid secretion. El Omar et al. [22] recently reported finding 11
patients with H. pylori infection who unexpectedly had achlorhydria, even when stimu-
lated to secrete acid. In the absence ofa non-invasive means ofdetecting achlorhydria and
no symptoms to suggest its presence, we can only speculate as to its true prevalence in the
community and to its incidence on initial infection.
EXPERIMENTAL EVIDENCE FOR THE ASSOCIATION
OF H. PYLORI AND ACHLORHYDRIA
The previous section provides clinical evidence for the association of H. pylori and
achlorhydria, but the mechanisms involved are not clear. The achlorhydria could be a
response to a factor(s) produced by the organism or mediated by the host itself. Itis known
that both E. coli [23] and Pseudomonas [24] lipopolysaccharide, given intravenously to
rats and dogs, respectively, can inhibit acid secretion. On the host side of the equation,
interleukin-1 has been shown to reduce acid secretion when given intravenously to rats
[25]. Similar finding have been reported with T cell growth factor. (There remains the
intransigent problem as to whether these factors are functioning as a physiological or
pharmaceutical agent in the doses used in these studies.
The likelihood of the achlorhydria being mediated by a cytokine released as part of
the inflammatory process ofthe gastritis process is low. This was particularly well demon-
strated in the Morris study [15] when the gastritis continued unabated after the volunteers'
acid secretion recovered, presumably with continued production of inflammatory
cytokines. Back diffusion of acid is unlikely to be the explanation, as evidenced by the
testing performed by Ramsey et al. [4] in the epidemic ofachlorhydria, leaving the possi-
bility of H. pylori itself causing the achlorhydria. It should be noted that in some of the
patients studied by Ramsey et al. [4] there was abolition ofboth basal and stimulated acid
secretion. Such a profound effect raises the possibility that the mechanism involves the
final common pathway of acid secretion.
Studies designed to establish animal models of Helicobacter infection have been
reported in several animal species, using various Helicobacter species. Intact animal stud-
ies in ferrets have shown thatwhen fournon-infected ferrets were infected with 1.5 x108.5
cfu ofH. mustelae, four weeks later they developed transient achlorhydria for two weeks,
as measured by elevated gastric pH. (pH 4-5.2) [26]. Interestingly, during this phase it was
possible to recover viable H. mustelae from the stool [27]. This suggests the concept that
the achlorhydric phase may be induced by the bacteria as a spreading mechanism, by
which it can find new hosts via the fecal/oral route. The subsequent return to normal lev-
els ofgastric secretion and the inability to subsequently culture H. mustelae from the stool
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supports this view. The achlorhydria occurs too late after infection has been established
for it to be regarded as a colonization factor. Canine gastritis has been reported in beagle
dogs infected with H.felis [28]. The dogs were infected at seven days ofage with 1 x 109
H. felis. At 30 days, immediately after euthanasia, the gastric pH was measured in five
dogs and was 7.7, 6.0, 2.6, 3.7 and 2.9; in two control dogs, the gastric pH was 2.0 and
3.6. Thus, there is evidence that H. felis can cause achlorhydria in an alternative host.
There are no reports ofchanges in acid secretion in other animal model systems.
The mediators ofthe hypochlorhydria seen in response to infection withH. pylori, H.
mustelae and H. felis have received some attention. In 1989, there were two preliminary
reports ofthe effect ofeitherwholeH.pyloriorits sonicate on theuptake of14C-aminopy-
rine, a weak base, into isolated gastric glands from rabbits orguinea pigs [29, 30]. In both
systems, there was a substantial reduction of uptake of the aminopyrine, which on entry
into low pH compartments ofthe cell becomes ionized and trapped. This method is wide-
ly accepted as a means ofmeasuring acid secretion in vitro. Cave andVargas expanded the
initial observations and were able to show that the effect on the parietal cells was not due
to alterations in protein synthesis [31]. The inhibitory factor was not significantly
impaired by heating to 600C for 30 minutes, but boiling for the same period destroyed its
activity. The material was not dialysable (12kD cut-off) and was present in low concen-
trations, especially in the bacterial supernatant. The factor was not inhibited by trypsin,
but was destroyed by pronase, a non-selective protease. Subsequently, the same group
evaluated the effect of different Helicobacter species on isolated rabbit and ferret gastric
glands [32]. They showed that H. pylori, H.felis and H. mustelae all caused acid inhibi-
tion, but with some variations in degree, depending on the individual isolate. Control
organisms, including Escherichia coli, Proteus vulgaris and Klebsiella oxytoca, had some
inhibitory effect on the 14C-aminopyrine uptake [33]. No effect was seen with
Campylobacterjejuni. The authors concluded that there may be a general property of
Helicobacterspecies that inhibit acid secretion in vitro. Jablonski et al. have shown a sim-
ilar effect with H. pylori on isolated human gastric glands obtained at surgical resection
[34]. Progress in this field has been slowed by difficulties in growing large amounts ofH.
pyloriand theinability to obtain sufficient material forbiochemical analysis. The problem
was solved by Kane et al. [35] who have been able to grow 10 liter batches of the bac-
terium in 24-48 hr to high optical densities. They used a bacterial fermenter and used one
percent cyclodextrin as a growth factor. Most importantly, they found that the anti-foam-
ing agent, used to minimize the froth formed when proteinaceous solutions are agitated,
was inhibitory to H. pylori. Elimination ofthis from the culture profoundly enhanced the
growth ofthe organism.
There are now fourcandidate factors forthe inhibition ofacid secretion: First, ammo-
nia is produced by all isolates ofH. pylori by the hydrolysis of urea by bacterial urease.
This base is present all the time that the organism is present, as a function of constitu-
itively-expressed urease and could not, therefore, account for the episodic nature of the
achlorhydria. Indeed, the etiologic role of ammonia in gastritis has been seriously ques-
tion by acute animal experiments in which sonicates of urease-positive and negative
mutants showed no differences in the resulting tissue injury, which was attributable to
cagA and vacA [36]. It is also arguable that there is insufficient ammonia to cause com-
plete neutralization of acid secretion. Second, Beil et al. [37] have shown that the fatty
acids, cis-9,10-methyleneoctadecanoic acid and tetradecanoic acid, are able to inhibit the
H+/K+-ATPase of isolated guinea pig parietal cells. These fatty acids, which are con-
stituents of the bacterial cell wall of H. pylori, gave comparable results to those with
lysates ofH. pylori. However, theexperiments wereperformeddifferently to those report-
ed by Cave et al. [38], who used an organic solvent to extract what they have called acid
inhibitory factor 2 (AIF-2). The fatty acids were used as emulsions because ofsolubility
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problems. Beil et al. suggested that the effect of these fatty acids explained the acid
inhibitory effectreported by Cave etal. as being due toAIF-2. The likely constitutive pres-
ence of the fatty acids do not explain the changes seen in acid secretion with respect to
time as discussed above. Huang et al. [39] have recently reported the purification of a
water soluble 92 kD protein from H. pylori that has two subunits of 46 kD. This protein
has an isoelectric point of7.3 and does not appear to be glycosylated. Preliminary evalu-
ation ofthe N-terminal amino acid sequence suggests that this is aunique protein as com-
pared with otherreported proteins. The lastfactor so fardescribed isAIF-2 [38]. The pres-
ence of this factor became apparent, when it was noted that there was residual acid
inhibitory activity afterAIF-1 had been inactivated by heating. This factor is much small-
er than AIF-1, being about 1-2 kD, and is extractable into a variety of organic solvents.
The solubility profile suggests that the molecule is comparable to nigericin, acyclic ether,
that functions as an ionophore for H+ and K+ ions. Preliminary studies using porcine vesi-
cles derived from gastric epithelium containing the K+/H+-ATPase, support this view.
Progress with further definition of this factor has been slow because ofits insolubility in
water. The solvents used to date all interfere with the 14C-aminopyrine assay. Thus, there
are a number ofcandidate molecules that might be involved with reduction ofacid secre-
tion. For one ofthem to be the causative factor in epidemic achlorhydria, it has to be afac-
tor that can be regulated, either by the bacterium itself of by environmental factors.
Clearly, a factor(s) that can cause such a profound change in a physiological process will
be of great interest.
EVIDENCE FOR THE INTERACTION OF H. PYLORIAND CHIEF CELLS
Interest in pepsin as a mediator ofpeptic ulcer disease has always played a subsidiary
role to that of acid secretion. This, at least in part, is due to the fact that measurement of
pepsin is much more difficult than hydrochloric acid and that there has been the tacit
assumption that the two are secreted together. That there is an increase in serum pepsino-
gens in ulcer disease has been known for many years. More recently, there has been the
demonstration that pepsin 1 becomes the predominant species in one-half to two-thirds of
patients with ulcer disease [40]. Pepsin 1 is biologically active over a much wider pH
range than the predominant pepsin 3 found in normal individuals. This observation was
extended to show that the degradation ofmucus by pepsin 1 was significantly more effec-
tive than by pepsin 3 [41]. The alteration of the serum pepsinogens, originally thought to
be genetically mediated, is now, clearly, a function ofH. pylori infection. Several authors
have described normalization ofthe changes after eradication of infection [13, 42].
The change in pattern of the serum pepsinogens and the increase in pepsin secretion
in response to H. pylori infection, which is a non-invasive organism, raises some impor-
tant questions as to how the changes are mediated. Are these changes a nonspecific
response to the inflammatory process? Do they reflect anatomical changes of bacterial
population? Or is this a specific signaled event? Two groups have started to examine the
possibility of there being a specific mechanism whereby H. pylon mediates changes in
pepsin release. Cave and Cave [43] tested three H. pylon isolates for their ability to stim-
ulate pepsin release from isolated gastric glands. Two of the three isolates significantly
increased pepsin release. This effect was additive to that of known stimulants such as
cholecystokinin or carbachol and isobutylmethlyxanthine, a phosphodiesterase inhibitor.
The effect was not blocked by atropine or cimetidine but was destroyed by boiling,
pronase treatment or dialysis (12 kD cutoff). They further confirmed that in these short
term experiments of 1 hr, there was no increase in the release of lactate dehydrogenase.
These data were interpreted to show that there was no immediate non-specific cell injury
and that pepsinogen release was mediated by a small peptide orprotein. The second group
used a different approach by testing for the release ofpepsin in an Ussing chamber [44].
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With this system, they were able to show that there was a 50-fold increase in release of
pepsin with one isolate of H. pylon and only 12-fold with E. coli. The method had the
advantage that whole tissues were used, and these could be monitored for function and
integrity by measurement ofresistance and current across the tissues. The preparation of
the sonicates and subsequent extraction showed the activity was present in the water sol-
uble component of the bacterial lipopolysaccharide. The lipopolysaccharide ofH. pylon
is, by most criteria, remarkably non-toxic as compared with that ofE. coli, implying that
the effect may be specific. The authors could not exclude the possibility ofan associated
peptide being the active ingredient. Thus, both studies suggest comparable molecules are
increasing pepsinogen secretion. Whether these factors are capable of not only releasing
pepsin into the lumen but also increasing serum pepsinogens remains to be defined.
Further purification and characterization ofthe factor(s) is awaited.
CONCLUSION
H. pylori has been shown, along with other Helicobacter species to produce effector
molecules that induce substantial physiological changes on acid andpepsin secretion. The
effects are clinically evident, and long-term achlorhydria may be a risk factor for gastric
cancer. Further identification and characterization of the factors may lead to additional
understanding ofgastric physiology.
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